Company Overview

Made public by

Medicine Man

sourced by PitchSend

16 of 23

Creator

Medicine Man

Category

Healthcare

Published

2020

Slides

Transcriptions

#1www.CO TORRES 10 SMEETS TO SUCK 10TH PERSWEET Business Overview Presentation February 2020 SOUR APPLE MEDICINE MAN Br TECHNOLOGIES MEDICINE MAN OTCQX: MDCL VHOTO PENTAGON#2MEDICINE MAN TECHNOLOGIES SAFE HARBOR STATEMENT 11 This presentation contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as "believes," "plans," "expects," "anticipates," "will," "should, "positioned" and words of similar import. Examples of forward-looking statements include, among others, statements regarding Medicine Man Technologies, Inc.'s (the "Company") operations, financial performance, business or financial strategies, or achievements. Forward-looking statements are neither historical facts nor assurances of future results or performance. Instead, they are based only on the Company's current beliefs, expectations and assumptions regarding the future of the Company's business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of the Company's control. Actual outcomes and results and the Company's financial performance and condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not rely on any of these forward- looking statements. Important factors that could cause actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following: the Company's ability to raise capital to finance any of its proposed acquisitions; the Company's ability to close on any of its proposed acquisitions; the Company's ability to successfully integrate and achieve its objectives with respect to any of its proposed acquisitions; the Company's ability to successfully execute its business, financial and growth strategy; the Company's ability to expand into additional states; the Company's ability to successfully offer new products, services and other offerings; the Company's ability to successfully implement its revenue growth strategy, generate cash flow from operations and achieve positive shareholder returns. Any forward-looking statement in this presentation is based only on information currently available to the Company and speaks only as of the date of this presentation. The Company disclaims any obligation to update any forward-looking statement or to announce publicly the results of any revisions to any forward-looking statement to reflect future events or developments except as required by law. The unaudited preliminary pro forma results and other financial information discussed in this presentation consists of estimates derived from the Company's internal books and records and has been prepared by, and are the responsibility of, the Company's management. The preliminary financial data are subject to the completion of financial closing procedures, final adjustments and other developments that may arise between now and the time the financial results for the fourth quarter ended December 31, 2019 are finalized. Therefore, actual results may differ materially from these preliminary financial data and all of these preliminary financial data are subject to change. 2#31. Executive Summary M MEDICINE MAN TECHNOLOGIES 3#4■ Medicine Man Technologies, Inc. ("Medicine Man Technologies" or the "Company") provides an established platform to facilitate the acquisition of companies under the leadership of CEO Justin Dye and his seasoned team ■ ■ ■ EXECUTIVE SUMMARY Medicine Man Technologies, Inc. (OTC Ticker: "MDCL”) is aggregating a premier portfolio of Colorado cannabis companies, positioning MDCL as one of the largest vertically-integrated operators in the state and a platform to lead consolidation and growth of cannabis in the U.S. Overview Since 2014 and headquartered in Denver, CO, the Company has historically provided consulting services, nutrients and supplies Upon legislation allowing outside investors into Colorado, the Company instituted a plant touching strategy backed by Dye Capital Justin Dye, former Albertsons Companies executive and Cerberus Capital operating executive, leads a best-in-class management team bringing Fortune 500 backgrounds and M&A / integration expertise The management team is primed to buy, integrate and synergize the portfolio of assets with a deep bench of cannabis entrepreneurs During the past year, the Company has entered into agreements to acquire 11 companies, which when closed will result in a scalable, vertically integrated Colorado operator All of the targets have a proven track record and are well positioned in their respective markets By establishing optimized operating procedures across the platform, the Company expects to extract significant benefits The retail strategy will implement product mix optimization, increased foot traffic technologies, targeted loyalty marketing and other sophisticated operating strategies For FYE 2019, the Company estimates pro forma revenue and EBITDA margins of $144MM (¹) and ~20%-30%, respectively 34 Dispensaries 64K Retail Sq. Ft. $3MM Avg. Revenue by Dispensary(2) Vertically Integrated Operations From Seed to Sale By the Numbers 13 Cultivation Sites 2.1MM Cultivation Sq. Ft. 100,000 Lbs / Year Note: These figures are unaudited and represent the Company's current estimates. These figures are subject to adjustment and change upon completion of the audits for each of the entities included therein (1) Revenue after elimination of $26MM of intercompany payments. PCAOB / Quality of Earnings audits currently underway, anticipated for completion April 2020 (2) Avg. revenue by dispensary based on FYE 2019 retail revenue / total expected retail stores post Colorado Rollup MEDICINE MAN 5 Manufacturing Facilities 23K Manufacturing Sq. Ft. >100 Products MEDICINE MAN TECHNOLOGIES OPEN 1 Consulting Practice 22 States with Strong Relationships 9 Success Nutrients™ Product Lines#5■ ■ Following successful closings of its announced acquisitions, MDCL will be the 6th largest U.S. vertically integrated cannabis operator in the nation by revenue, with positive EBITDA - a key differentiator versus the industry ■ Legacy Cannabis Aggregated significant capital at unsustainable multiples Deployed capital intensive multi-state strategies Inefficient operating structures with limited profitability Limited operating experienced management teams ($USD in millions) $300 $250 $200 $150 SIGNIFICANT OPERATOR WITH KEY DIFFERENTIATION $100 $50 ($50) ($100) ($150) ($200) $144 (3) $36 MM MEDICINE MAN TECHNOLOGIES $295 ($24) curaleaf. $209 $77 $161 ($19) Trulieve GTI $152 ($189) Last Twelve Months Revenue and EBITDA (¹) MedMen $152 ($76) ■ CRESCO LABS ■ ■ ■ Very attractive entry points Single mature state maximizes economies of scale $122 Aggregating assets with track records of revenue and profitability Current team has a track record of success working together ($125) $96 EBITDA The MDCL Difference ($83) TILT HARVEST $65 ($83) COLUMBIA CABL $64 ($153) Acreage. HOLDINGS $53 MMEDICINE MAN ($51) ¡Anthus TECHNOLOGIES $28 ($69) GREEN GROWTH BRANDS Revenue Note: Company figures are unaudited and represent the Company's current estimates. These figures are subject to adjustment and change upon completion of the audits for each of the entities included therein Source: Public company filings (1) Pro forma for publicly announced deals | (2) Revenue after elimination of $26MM of intercompany payments. PCAOB / Quality of Earnings audits currently underway, anticipated for completion April 2020 | (3) EBITDA based on mid point of Company's 20% - 30% EBITDA margin guidance 5#6Company Medicine Man Technologies Pro forma organization includes 34 dispensaries, 13 cultivations, 5 manufacturing facilities (MIPs) and 1 consulting business unit. Pro forma combination generates FY'19 estimates of ~$144MM of revenue (¹) Starbuds Medicine Man Denver Straw berry Fields Project X Medically Correct Los Sueños Roots Rx Colorado Harvest Company Purplebee's Canyon Dabble Extracts Total Locations Total Sq. Ft. (000's) MEDICINE MAN TECHNOLOGIES M MEDICINE MAN Strawberry Fields Medically Correctuc LOS Sueños RECREATIONAL COLORADO X Purplebee's- CANVON PRO FORMA COMPANY SNAPSHOT W DABBLE Retail 13 4 4 6 3 4 34 64 Cultivation 1 1 1 2 4 2 2 13 Wholesale 2,139 Manufacturing 1 1 1 1 1 5 23 Other (2) 3 3 MEDICINE MAN TECHNOLOGIES Medicine Man Technologies Benefits from Several Factors of the Colorado Market Governor Polis embraces the industry and focused on pushing a customer- focused approach to regulation Clear Regulatory Structure Conducive to Business Modest sales tax regime compared to other states High Customer Adoption Rate Nearly twice of Coloradoans participate compared to other states (3) Large, Highly Fragmented Market Note: These figures are unaudited and represent the Company's current estimates. These figures are subject to adjustment and change upon completion of the audits for each of the entities included therein (1) Revenue after elimination of $26MM of intercompany payments. PCAOB / Quality of Earnings audits currently underway, anticipated for completion April 2020 (2) Inclusive of consulting, Big Tomato and Success Nutrients™ businesses (3) Wall Street research. At an estimated 25%, the illicit market is quite low compared to other states (3) 6#7■ Medicine Man Technologies is designed to be vertically integrated, allowing it to control the product at every level, ensuring quality and distribution and allowing it to maximize profits and the consumer experience CULTIVATION MEDICINE MAN TECHNOLOGIES GROWS POTENT, HIGH-YIELDING CANNABIS SUITABLE FOR FLOWER CONSUMPTION OR INFUSED PRODUCTS FULL VERTICAL INTEGRATION 13 OPERATIONAL FACILITIES IMPLEMENT THREE A LIGHT™ PROCEDURES TO BOOST FLOWER QUALITY AND YIELDS FAR ABOVE THE INDUSTRY AVERAGE MANUFACTURING BRAND BUILDING EXPERTISE COMBINED WITH ATE OF THE ART CAPABILITIES PROVIDES OPPORTUNITY FOR WHOLESALE AND PRIVATE LABEL GROWTH 5 OPERATIONAL FACILITIES CONSOLIDATE BEST PRACTICES THROUGHOUT ALL MANUFACTURING FACILITIES RETAIL CUSTOMER-CENTRIC RETAIL STRATEGY SUPPORTED BY A VARIETY OF BANNERS THAT HAVE STRONG LOCAL TIES AND TAILORED MERCHANDISING 34 TOTAL LICENSED DISPENSARIES ■ COLORADO LEGISLATION TO ALLOW ECOMMERCE IN Q1 2021 ■ MEDICINE MAN TECHNOLOGIES Comprehensive Support Across Supply Chain CONSULTING EXTENSIVE CONSULTING BACKGROUND IN THE INDUSTRY WITH LONGSTANDING RELATIONSHIPS TO SUPPORT OPERATIONAL IMPROVEMENT AND MULTI-STATE GROWTH CONSULTING IN 22 STATES LEVERAGE EXPERTISE AND NETWORK FOR POTENTIAL PARTNERSHIPS AND INORGANIC GROWTH OPPORTUNITIES 7#81 Medicine Man Technologies' vision is to build the most admired cannabis company in the world by devoting its resources to recognize the full potential of cannabis and provide high-quality products to improve the human condition 2 3 4 5 MEDICINE MAN TECHNOLOGIES' VISION Incorporate into our DNA a purpose-driven value system which supports the health and well being of our customers Build strong brands - New corporate name and messaging coming online in the first half of 2020 We are in the business of compliance to earn the right to connect with our customers everyday Customer facing initiatives will be linked to sustainable business practices Build path to healthy free cash flow to reinvest in our assets, customers and people Build best-in-class management team with deep bench of future leaders Install Phase I of our Blueprint: The Operating System & Processes Identify investment / growth pipeline while closing CO roll-up transactions Set KPIs for monitoring performance Create industry leadership within scalable digital technologies, omnichannel commerce and innovation ERP technology and integration rollout schedule defined Build digital war chest, including personalized loyalty platform ■ eCommerce Customer-centric thinking with data driven decision making is at the core of everything we do Internal and third party data providers and teams onboarded to drive data driven decision making Marketing / merchandising / operating playbooks start with the customer and work backward Test, Learn, Implement: customer data and participation to define our new product roadmap direction Foster a culture of getting better everyday while being known as a fun, innovative and inspiring place to work Leadership philosophy and values: Relentless pursuit to get better every single day High performing organizational structure and design University System for continuing education, training, communication and career advancement Skunk Works Innovation Lab and capabilities ■ ■ MEDICINE MAN TECHNOLOGIES 8#9II. Investment Highlights MMEDICINE MAN TECHNOLOGIES 9#101 2 3 4 KEY INVESTMENT HIGHLIGHTS Medicine Man Technologies has many points of differentiation Best-in-Class Management Team Hypergrowth Industry With Growth Trajectory Starting From Market Leading Position in Colorado Great Expertise In Retail, Manufacturing, Brand Development and Product Development M.MEDICINE MAN This Team Has Done This Before: Buying, Integrating And Synergizing Assets in Other Industries Which Delivered Outsized Shareholder Returns TECHNOLOGIES 10#111.0 EXPERIENCED MANAGEMENT TEAM Medicine Man Technologies has a best-in-class management team with premier operational practices, combining cannabis expertise with large-cap Fortune 500 executives, positioning the Company for revenue enhancements, increased profitability and immediate actionable growth Albertsons Justin Dye, Chief Executive Officer and Chairman: 25+ years of experience in private equity, general management, operations, corporate finance and M&A. He led the growth of Albertsons from ~$10Bn to over ~$60Bn in sales with over 2,300 stores and 285,000 employees, creating one of the largest privately held companies in the U.S. Shane Sampson, Chief Marketing and Merchandising Officer: 35+ years experience building iconic brands and leading innovative marketing and merchandising programs; expertise spans operations, product merchandising and procurement, eCommerce and branding. He has scaled and led a $12Bn private label products company. Bob DeGabrielle, Chief Operating Officer: Among the trailblazers in the legal cannabis space, Bob is a founding member of the Cannabis Trade Association and owner and operator of Los Sueños Farms, one of the largest outdoor sustainable cultivations in the U.S. Rob Holmes, SVP Real Estate: Founder of Roots Rx in 2014, a seed-to-sale cannabis operator in Colorado's resort region, he brings 35+ years of experience in finance, risk management and real estate at Salomon Brothers, Lehman Brothers and Greenwich Capital. Companies CREDIT SUISSE cerberus **RBS Greenwich Capital UND STATES AIR FORGE cip Ahold MEDICINE MAN TECHNOLOGIES Nancy Huber, Chief Financial Officer: Successful track record with 30+ years of experience managing public enterprises and overseeing multifunctional management. As CFO of a CPG company, she oversaw improvements in revenue, margins and EBITDA. Nancy received her MBA from Kellogg School of Management. Nirup Krishnamurthy, Chief Integration and Information Officer: Dye Capital Partner carrying 25+ years of experience in innovation, technology, restructuring and M&A in Fortune 500 companies, holding executive roles at United Airlines, Northern Trust Bank and A&P Supermarkets. Nirup holds a PhD in Industrial Engineering from SUNY. Dan Pabon, General Counsel and Government Relations: Experienced former Colorado State Representative who was instrumental in the passing and writing of cannabis laws in Colorado. Dan has 15+ years of expertise in emerging regulatory systems, legal research and legislative relations. Steve Miller, SVP Real Estate: Consultant to Roots Rx since 2014. Brings 35+ years of experience at Credit Suisse and Greenwich Capital where he focused on mortgage securities and asset backed products. Steve's expertise also lies in small entrepreneurial firms with both public and private investments. citi UNITED AIRLINES DYE CAPITAL SAFEWAY & COMPANY 11#121.0 EXPERIENCED MANAGEMENT TEAM (CONT.) Medicine Man Technologies has a best-in-class management team with premier operational practices, combining cannabis expertise with large-cap Fortune 500 executives, positioning the Company for revenue enhancements, increased profitability and immediate actionable growth Albertsons Lee A. Dayton, Jr, Chief Investment Officer: 25 years of experience in investment banking and corporate development. More recently, he served as VP of Corporate Development and Strategy at Albertsons Companies, focused on high growth customer-focused technologies. Prior to that, Lee worked as an investment banker at UBS, Morgan Stanley and Citigroup. Lee received an MBA from Kellogg School of Management. Shelle Cleveland, Chief Human Resources Officer: 25 years of experience in leading and creating meaningful change in high performance organizations. Shelle has collaborated with leaders across a wide spectrum at General Electric. From CEOs and C-suite executives to mid-level and future leaders, Shelle uses her diverse background to instill change. Shelle received an MBA from Kellogg School of Management. Joshua Haupt, Chief Cultivation Officer: Joshua Haupt, recognized as the "Steve Jobs of cannabis cultivation," has been recognized for his innovative growing technique and entrepreneurship in the Cannabis industry. Josh perfected his growing methodology and is now the Chief Cultivation Officer at Medicine Man Technologies, author of Three A Light TM, founder of Success Nutrients TM and owner of Super Farm. Companies CREDIT SUISSE cerberus **RBS Greenwich Capital UND STATES AIR FORGE cip Ahold M MEDICINE MAN TECHNOLOGIES Todd Williams, Chief Strategy Officer: 24 years of consulting, strategy, asset valuation and M&A experience. In his most recent role at Albertsons Companies, he managed the acquisition of over 1,600 operating grocery stores with ~$40Bn in sales and $10 billion in transaction value and was also responsible for divesting 168 stores with over $3Bn in sales. Jim Parco, President of Manufacturing: In 2014, Jim Parco founded Mesa Organics (Purplebee's) which is the leading Colorado extractor and manufacturer, as well as producer of cannabis products for some of the leading edible companies across the state. Prior to that, Jim served two decades of active duty in the Air Force and was a tenured full professor of economics and business for nine years at Colorado College. Jim holds his PhD from University of Arizona. Brian Ruden, Board of Directors: Since 2010, Brian Ruden has owned and operated cannabis businesses under the Starbuds brand. Under his leadership, Starbuds has become one of the most recognized and successful retail cannabis operations in North America. In 2014, Brian founded Starbuds Consulting, a consulting company providing strategic advice to start-up cannabis operations. UNITED AIRLINES citi DYE CAPITAL SAFEWAY & COMPANY 12#13■ I ■ Colorado is an attractive geography to start our story, where market participants are sophisticated, profitable and have weathered the boom and bust economic cycle of early cannabis CO is the 2nd largest U.S. cannabis market and continues to grow: $1.6Bn of revenue today, with anticipated growth to ~$1.9Bn by 2022(¹) $12.9Bn revenue U.S. market today, projected to nearly double by 2022 to $23.5Bn(¹) 11 states have legalized recreational cannabis, 33 states legalized medical cannabis and 47 states legalized low THC 2019 Beer Sales 2.0 Many experts believe the U.S. Government will ease restrictions on States' Rights to legalize cannabis, including clarification on States Act, banking laws and/or outright legalization, but clearly no guarantees 2019 Cigarette Sales 2030E Legal Cannabis Market Size 2019 Organic Food Sales Cannabis Poised to Surpass many Prominent U.S. Industries (²) 2019 Wine Sales FUNDAMENTAL ATTRACTIVE MARKET 2019 Video Game Sales Commentary 2018 Firearms & Amunition Sales 2019 Legal Cannabis Market Size 2019 E-Cirarette Sales $17.0Bn $12.9Bn $5.9Bn $ 52.5Bn $48.8Bn $35.4Bn $90.5Bn $75.0Bn Built-in Growth Rate ~17% CAGR $114.2Bn (1) BDS Analytics - for use by Medicine Man Technologies only (2) Brewers Association, Statista, Wall Street research, Organic Trade Association, Entertainment Software Association, IBIS World State CA 8 FL MI AZ Other Total Legalization Momentum Continues to Expand D 2019E $3.10Bn $1.62Bn $978MM Colorado Ranks as the 2nd Largest Cannabis Market (¹) $1.0Bn $705MM $5.51Bn $12.90Bn 2020E $3.78Bn $1.70Bn $1.22Bn $1.21Bn $804MM $7.64Bn Legal $16.34Bn Medical Use Only CBD (Low THC) Only Prohibited D Decriminalized 2021E $4.57Bn $1.78Bn $1.44Bn $1.29Bn $965MM $9.56Bn $19.60Bn MEDICINE MAN TECHNOLOGIES 2022E $5.62Bn $1.87Bn $1.62Bn $1.35Bn $1.16Bn $11.90Bn $23.53Bn 13#14■ ■ Medicine Man Technologies will have a leading position in the Colorado market throughout its operations with significant enhancement and optimization opportunities ■ ■ 2.0 MARKET LEADING POSITION The current fragmented state of the Colorado cannabis market creates a ripe opportunity for consolidation Leading, Scalable Cannabis Platform Benefits Expertise across each of its key operating areas to maximize efficiencies Customer data to take advantage of market trends Broad retail and product brand portfolio to compliment merchandising strategy Control over shelf space allowing for positioning of in-house brands CANYON DABBLE EXTRACTS Purplebee's Note: These figures are unaudited and represent the Company's current estimates. These figures are subject to adjustment and change upon completion of the audits for each of the entities included therein (1) Colorado Marijuana Enforcement Division 12/02/2019. Charts not to scale, shown for illustrative purposes only Retail (Dispensaries by Company) Wholesale (MIPS by Company) (Cult. Sites by Company) 467 Vertically Integrated Leader(¹) 275 649 #1 34 5 #1 13 #1 22 21 14 14 2 15 Consolidated Company The Green Solution ■ Native Roots Green Dragon LivWell Other Consolidated Company ■Competitor 1 Competitor 2 Competitor 3 Competitor 4 Other Consolidated Company Rocky Mountian Tillage Rocky Mountian Remedies LivWell Lightshade Other M.MEDICINE MAN TECHNOLOGIES 14#152.0 EXPANSIVE POST CONSOLIDATION FOOTPRINT 491 The post consolidated platform will be able to reach an estimated 75% of the mature Colorado cannabis market(¹) Grand Junction 160 Montrose 550 Durango 50 Steamboat Springs Gotte 160 40 cffff Edwar dies 50 Colorado 285 34 285 40 160 287 50 COLORADO Fort Collins Sveland PHI Boulder Broom T 470 etttt 20 Alte Con Cañon City. Greeley Colorado Springs cttt TOA (1) Estimated Company reach based on population in nearby counties to dispensaries. Population statistics based on U.S. Census www blo 50 k 160 Fort Morgan 350 ttttt 190 Fairmount Applewood East Pleasant View OSO 470 160 Broomfield 4 Dakota Ridge ARVADA 121 Wheat Ridge THORNTON WESTMINSUB 4X IPA 3² LAKEWOOD 121 Greater Denver COOOO OA HAL Edgewater 470 36 Berkley Columbine Northglenn Bow Mar 70 33 Att 25 06 -Littleton Welby DENVER te PAK Englewood Co m Comme City atti IPA Southglenn Highlands Ranch Hendersón Pat Schroeder Visitor Center fffff. PAI Atte MIP AUD JOAI Cherry Creek State Park Castlewood AURORA CENTENNIAL Legend Symbol Type Sites Dispensary 34 Cultivation 13 5 att MMEDICINE MAN Foxfield Cottonwood TECHNOLOGIES North A Sa 15#163.0 CUSTOMER-CENTRIC RETAILING Medicine Man Technologies' DNA is a purpose-driven value system which supports the health, well being and happiness of its customers. Data driven customer-centric thinking drives company operations and innovation. MDCL will deliver what the customers want - where, when and how they want it Accessories / Apparel Premium (Destination) Mainstream (Convenience) Value (Price Conscious) Adventurous (Experiential) Consumption Lounge Consumer Data Concentrates Store Formats That Fit Customers' Lifestyles Point of Sale Flower and Pre-Rolls Products and Brands That Match Customers Demands Edibles Indies Non-Users Grow Supplies Sublinguals Competitive Intelligence Outsiders Idealists Retail Analytics & Consumer Engagement Tools Sales Force/ HRMS Business Intelligence Marketing Agency Topicals Omnichannel (When, Where and How) Website/App Coordination Shake/Trim MDCL eCommerce Marketplace eCommerce Drive Up and Go Same Day Delivery Next Day Delivery Subscription MEDICINE MAN TECHNOLOGIES Personalized Loyalty Legend In Development Existing Capability 16#17CANNABIS RETAIL 2.0 2019 Combining best-in-class retail practices with industry leading cannabis expertise, MDCL will lead innovation in the development of product and retail trends Interactive Digital Experiences SHERBIN 3.0 CANNABIS EXPERIENTIAL RETAIL 2017 2013 Premium Experiential Branding Tasting Lounge COFFEE +FLOWERS Store Within A Store Concepts Consumption & Event Venue 無 : www 酒 酒 eCommerce Concierge (click & collect, subscription) MMEDICINE MAN TECHNOLOGIES 17#184.0 PROVEN M&A AND INTEGRATION EXPERTISE Led by Justin Dye and critical members of the previous Albertson's management team, Medicine Man Technologies is uniquely positioned with world-class management and acquisition capabilities to grow the Company to become a global cannabis leader ■ ■ ■ Executive Justin Dye Dye and his team transformed Albertsons into the leader in the U.S. supermarket industry Pursuing a highly successful acquisition strategy Instituting best-in-class operating procedures in a low margin business Achieving unprecedented company growth Scaling the company from ~$10Bn to ~$60Bn revenue over a three-year period MDCL plans to implement a similar growth strategy through acquisitions in the cannabis industry MDCL's team has done this before: buying, integrating and synergizing assets, which delivered outsized shareholder returns Shane Sampson Todd Williams Nirup Krishnamurthy This Team Has Done This Before... Former Role at Albertsons ■ COO and CAO ▪ Head of Integration ▪ CMMO Head of Revenue Synergies ▪ VP, Corporate Development ▪ M&A Leader ▪n/a, former CIO at United Airlines Source: Albertsons Investor Presentation dated May 15, 2018 Current Role at MDCL ▪ Chairman and CEO ▪ CMMO ▪ Head of Revenue Synergies ▪ Chief Strategy Officer ▪ M&A and Capital Committee Leader Chief Integration & Information Officer ■ IMO and ERP Lead ...With History of Outperforming Announced Synergy Targets Albertsons Companies Synergies Planned At Announcement: $800MM SAFEWAY MEDICINE MAN TECHNOLOGIES 2018 Run-Rate: $823MM 18#19I ■ ■ ■ ■ ■ ■ ■ ■ 4.0 ■ RETAIL NEW STORES Fill-In Acquisitions Distressed Asset Acquisition REPLICABLE ORGANIC GROWTH PLAYBOOK MERCHANDISING New Geographies with Legislative Changes New Formats and Lounges Business model is transferable and enables roll out for multistate expansion New Products Data-Driven Category Management Pricing and Promotion Placement and Presentation OPERATING CONDITION Out of Stocks ■ Suggestive Sales Methodology and Training ■ Inventory Management eCOMM Full Merchandising, Fresh Looking Products, Friendly Staff, Clean Facilities WHOLESALE COF FEE NITRO LEVERAGE BEST PRACTICES Upgrade Sales Organization Account Convergence and Management Sales Incentive Practices Cross-Sell Products into Underpenetrated Accounts SIMPLIFY VENDOR MANAGEMENT One Point of Contact for Dispensary Customers Rigorous Coordination between Sales Staff, Marketing and Supply Chain NEW PRODUCTS B2B: Grow Flower, Trim and Oil New Product Roadmap To Meet Future Customer Wants & Needs Grow Medical Cultivation Capacity I I SERVICES Success Nutrients (plant nutrient line) Big Tomato (grow supplies) ■ Three-A-Light (cultivation IP) I NEW CHANNELS NEW STATES MMEDICINE MAN Target Key States for Consulting Services Unit Tied to Partnerships and Acquisition Pipeline NEW OFFERINGS Add Manufacturing Suite Add New Pricing Tiers to Suite of Services Facility and Equipment Design Mechanical, Electrical and Plumbing Engineering Services and Procurement TECHNOLOGIES 19#20■ ■ ■ 4.0 CONSULTING IS A KEY ENABLER OF EXPANSION Through its consulting practice, the Company has developed a strong presence in 22 states and intends to use its deep relationships to pursue future acquisition targets and potentially garner significant market share in new, attractive regions The Company has established itself as one of the leading cannabis consultants in the country and has developed strong ties with cannabis operators in 22 states The Company relies on its consulting work to gather insights into market dynamics and state cannabis regulations and procedures, so it can better understand the merits and challenges when looking to expand outside of Colorado MDCL's consulting work helps the Company identify attractive acquisition targets that can enable the Company to establish a substantial market position and strong brand presence in new regions MDCL also has the option to partner with or acquire many of its clients' companies due to the ease of integration and reduction of costs through operational restructuring WA OR AK NV UT AZ MT WY CO NM ND SD NE TX KS OK MN IA MO AR Currently Established WI IL IN MS MI KY TN AL OH GA WV PA SC VA NC MMEDICINE MAN NY TECHNOLOGIES ME 20#211 2 3 4 KEY INVESTMENT HIGHLIGHTS Medicine Man Technologies has many points of differentiation Best-in-Class Management Team Hypergrowth Industry With Growth Trajectory Starting From Market Leading Position in Colorado Great Expertise In Retail, Manufacturing, Brand Development and Product Development M.MEDICINE MAN This Team Has Done This Before: Buying, Integrating And Synergizing Assets in Other Industries Which Delivered Outsized Shareholder Returns TECHNOLOGIES 21#22Thank you! Investor Contact Information: Medicine Man Technologies, Inc. 4880 Havana Street, Suite 201 Denver, CO 80239 IR@MedicineMan Technologies.com 22

Download to PowerPoint

Download presentation as an editable powerpoint.

Related

Fiscal 3Q Investor Presentation image

Fiscal 3Q Investor Presentation

Healthcare

FY23 Full-Year Results Presentation image

FY23 Full-Year Results Presentation

Healthcare

Healthcare Network P&L Statement and Expansion Projects image

Healthcare Network P&L Statement and Expansion Projects

Healthcare

Accreditation and Quality Assurance Overview image

Accreditation and Quality Assurance Overview

Healthcare

Investment Highlights image

Investment Highlights

Healthcare

Investor Presentation image

Investor Presentation

Healthcare

IDEAYA Biosciences Interim IDE397 Phase 1 Clinical Data and Q1 2022 Corporate Update image

IDEAYA Biosciences Interim IDE397 Phase 1 Clinical Data and Q1 2022 Corporate Update

Healthcare

BioAtla Investor Presentation Deck image

BioAtla Investor Presentation Deck

Healthcare